• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Metals
    Tech
    Life Science
    Life Science Market
    Life Science News
    Life Science Stocks
    • Life Science Market
    • Life Science News
    • Life Science Stocks
    market news

    Caltech Biologists Develop Long-Term Contraception Shot

    Morag Mcgreevey
    Oct. 07, 2015 10:08AM PST
    Life Science Investing News

    Biologists at the California Institute of Technology have developed a shot that gives male and female animals long-term contraception.

    Biologists at the California Institute of Technology have developed a shot that gives male and female animals long-term contraception.
    According to an article on Pharmaceutical Processing:

    ​Caltech biologists have developed a nonsurgical method to deliver long-term contraception to both male and female animals with a single shot.
    The technique—so far used only in mice—holds promise as an alternative to spaying and neutering feral animals.
    The approach was developed in the lab of Bruce Hay, professor of biology and biological engineering at Caltech, and is described in the October 5 issue of Current Biology. The lead author on the paper is postdoctoral scholar Juan Li.
    Hay’s team was inspired by work conducted in recent years by David Baltimore and others showing that an adeno-associated virus (AAV)—a small, harmless virus that is unable to replicate on its own, that has been useful in gene-therapy trials—can be used to deliver sequences of DNA to muscle cells, causing them to produce specific antibodies that are known to fight infectious diseases, such as HIV, malaria, and hepatitis C.

     
    Click here to read the full article on Pharmaceutical Processing.

    market newsinfectious diseases
    The Conversation (0)

    Go Deeper

    AI Powered
    Senior woman doing exercises alongside closeup of DNA.

    5 US Longevity and Anti-aging Stocks to Watch in 2025

    Test tubes.

    Biotech Market Forecast: Top Trends for Biotech in 2025

    Latest News

    Seegnal Inc. Announces Extension of Maccabi Health Services Contract

    Phase 2 HER2 Clinical Trial Manufacturing Commenced, WSU Imaging Optimisation Program Underway

    More News

    Outlook Reports

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Stocks

    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES
    Ă—